CRISPR Therapeutics Q4 2024 Earnings Report

Total Revenue
$35M
Previous year: $201M
-82.6%
EPS
-$0.44
Previous year: $1.1
-140.0%

CRISPR Therapeutics

CRISPR Therapeutics